Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Istvan Toth

Showing results (331-340 of 335) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 335 results.
Vaccines|April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A <i>Streptococcus</i> Pharyngeal Infection in a Non-Human Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Science Advances|February 18, 2020
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccinesMariusz Skwarczynski, Guangzu Zhao, Jennifer C Boer, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Molecules (Basel, Switzerland)|January 20, 2021
A Global Review on Short Peptides: Frontiers and PerspectivesVasso Apostolopoulos, Joanna Bojarska, Tsun-Thai Chai, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 17, 2026
Development of a Novel Polyleucine-Based Immunopotentiator for Subunit Vaccines Against Group A StreptococcusLantian Lu, Jazmina L Gonzalez Cruz, Rabina Giri, et al.
Pageof 34

Showing results (331-340 of 335) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 335 results.
Vaccines|April 27, 2024
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A <i>Streptococcus</i> Pharyngeal Infection in a Non-Human Primate ModelTania Rivera-Hernandez, Diane G Carnathan, Johanna Richter, et al.
Science Advances|February 18, 2020
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccinesMariusz Skwarczynski, Guangzu Zhao, Jennifer C Boer, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Molecules (Basel, Switzerland)|January 20, 2021
A Global Review on Short Peptides: Frontiers and PerspectivesVasso Apostolopoulos, Joanna Bojarska, Tsun-Thai Chai, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 17, 2026
Development of a Novel Polyleucine-Based Immunopotentiator for Subunit Vaccines Against Group A StreptococcusLantian Lu, Jazmina L Gonzalez Cruz, Rabina Giri, et al.
Pageof 34